Cargando…
Cytotoxic activity of bromodomain inhibitor NVS-CECR2-1 on human cancer cells
Bromodomain (BRD), a protein module that recognizes acetylated lysine residues on histones and other proteins, has recently emerged as a promising therapeutic target for human diseases such as cancer. While most of the studies have been focused on inhibitors against BRDs of the bromo- and extra-term...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7529788/ https://www.ncbi.nlm.nih.gov/pubmed/33004947 http://dx.doi.org/10.1038/s41598-020-73500-7 |